Urinary excretion of liver-type FABP as a new clinical marker for the progression of obstructive nephropathy

Biomarkers in Medicine

Volumn 8, Issue 4, 2014, Pages 543-556

  Xie, Yuanyuan ^a   Xu, Weijia ^a   Wang, Qin ^a   Shao, Xinghua ^a   Ni, Zhaohui ^a   Mou, Shan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

acute kidney injury; combined markers; diagnosis; Kaplan Meier method; liver type FABP; NGAL; obstructive nephropathy; receiver operating characteristic area under the curve; renal prognosis; urinary marker

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CHOLESTEROL; CREATININE; FATTY ACID BINDING PROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TRIACYLGLYCEROL; ACUTE PHASE PROTEIN; FABP3 PROTEIN, HUMAN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CELL COUNT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE NEPHROPATHY; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE PERIOD; PROGNOSIS; PROTEIN URINE LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SURVIVAL; TRIACYLGLYCEROL BLOOD LEVEL; URINARY EXCRETION; ACUTE KIDNEY INJURY; BLOOD; LIVER; METABOLISM; MIDDLE AGED; PATHOLOGY; STATISTICAL MODEL; URINE;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; ADULT; AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; CREATININE; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACID-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LINEAR MODELS; LIPOCALINS; LIVER; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84899801011     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.13.136     Document Type: Article

References (17)

1. Smith JM, Stablein DM, Munoz R et al. Contributions of the transplant registry: the 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). Pediatr. Transplant. 11(4), 366-373 (2007).
2. Chevalier RL, Thornhill BA, Forbes MS et al. Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy. Pediatr. Nephrol. 25(4), 687-697 (2010).
3. Dear JW, Yuen PS. Setting the stage for acute-on-chronic kidney injury. Kidney Int. 74(1), 7-9 (2008).
4. Ferguson MA, Vaidya VS, Waikar SS et al. Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int. 77(8), 708-714 (2010).
5. Levey AS, Coresh J, Greene T et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin. Chem. 53(4), 766-772 (2007).
6. Mehta RL, Kellum JA, Shah SV et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit. Care 11(2), R31 (2007).
7. Han WK, Wagener G, Zhu Y, Wang S, Lee HT. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin. J. Am. Soc. Nephrol. 4(5), 873-882 (2009).
8. Chevalier RL. Obstructive nephropathy: towards biomarker discovery and gene therapy. Nat. Clin. Pract. Nephrol. 2(3), 157-168 (2006).
9. Glatz JF, van der Vusse GJ. Cellular fatty acid-binding proteins: their function and physiological significance. Prog. Lipid Res. 35(3), 243-282 (1996).
10. Kamijo A, Sugaya T, Hikawa A et al. Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am. J. Pathol. 165(4), 1243-1255 (2004).
11. Nakamura T, Sugaya T, Node K et al. Urinary excretion of liver-type fatty acid-binding protein in contrast mediuninduced nephropathy. Am. J. Kidney Dis. 47(3), 439-444 (2006).
12. Portilla D, Dent C, Sugaya T et al. Live fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int. 73(4), 465-472 (2008).
13. Kamijo A, Sugaya T, Hikawa A et al. Clinical evaluation of urinary excretion of liver-type fatty acid binding protein as a marker for monitoring chronic kidney disease: a multicenter trial. J. Lab. Clin. Med. 145(3), 125-133 (2005).
14. Mou S, Wang Q, Ni Z et al. Urinary excretion of livertype fatty acid-binding protein as a marker of progressive kidney function deterioration in patients with chronic glomerulonephritis. Clin. Chim. Acta 413(1-2), 187-191 (2012).
15. Kamijo A, Sugaya T, Hikawa A et al. Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. Mol. Cell Biochem. 284(1-2), 175-182 (2006).
16. Haase M, Bellomo R, Devarajan P et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am. J. Kidney Dis. 54(6), 1012-1024 (2009).
17. Kamijo A, Sugaya T, Kimura K. Urinary fatty acid binding protein in renal disease. Clin. Chim. Acta 374(1-2), 1-7 (2006).